Cargando…
The Evolution of Sodium-Glucose Co-Transporter-2 Inhibitors in Heart Failure
Sodium-glucose co-transporter-2 (SGLT2) inhibitors have evolved over the years, based on data from several randomized, double-blinded, placebo-controlled clinical trials. Formerly used primarily for blood sugar control in patients with diabetes, they are now used to decrease the risk of hospitalizat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654149/ https://www.ncbi.nlm.nih.gov/pubmed/34925982 http://dx.doi.org/10.7759/cureus.19379 |